NO159271C - Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater. - Google Patents
Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater.Info
- Publication number
- NO159271C NO159271C NO842003A NO842003A NO159271C NO 159271 C NO159271 C NO 159271C NO 842003 A NO842003 A NO 842003A NO 842003 A NO842003 A NO 842003A NO 159271 C NO159271 C NO 159271C
- Authority
- NO
- Norway
- Prior art keywords
- isoqinoline
- derivatives
- preparation
- therapeutic active
- image
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/496,327 US4544657A (en) | 1983-05-19 | 1983-05-19 | Substituted isoquinolines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842003L NO842003L (no) | 1984-11-20 |
| NO159271B NO159271B (no) | 1988-09-05 |
| NO159271C true NO159271C (no) | 1988-12-14 |
Family
ID=23972146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842003A NO159271C (no) | 1983-05-19 | 1984-05-18 | Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4544657A (pt) |
| EP (1) | EP0126480B1 (pt) |
| JP (1) | JPS59222478A (pt) |
| KR (1) | KR840009102A (pt) |
| AT (1) | ATE32072T1 (pt) |
| AU (1) | AU570044B2 (pt) |
| CA (1) | CA1243028A (pt) |
| DE (1) | DE3468875D1 (pt) |
| DK (1) | DK248484A (pt) |
| ES (1) | ES532603A0 (pt) |
| FI (1) | FI81795C (pt) |
| GR (1) | GR82015B (pt) |
| HU (1) | HU192555B (pt) |
| IL (1) | IL71860A (pt) |
| MC (1) | MC1597A1 (pt) |
| NO (1) | NO159271C (pt) |
| NZ (1) | NZ208186A (pt) |
| PH (1) | PH19670A (pt) |
| PT (1) | PT78618A (pt) |
| ZA (1) | ZA843748B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2124511C1 (ru) * | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
| US5681954A (en) * | 1993-05-14 | 1997-10-28 | Daiichi Pharmaceutical Co., Ltd. | Piperazine derivatives |
| FR2840896B1 (fr) * | 2002-06-18 | 2005-04-08 | Sanofi Synthelabo | Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| EP2392571A3 (en) | 2005-07-29 | 2012-03-14 | F. Hoffmann-La Roche AG | Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759443A (fr) * | 1970-09-15 | 1971-04-30 | I F L O Istituto Farmacologico | Nouveau derive papaverolinique et procede de preparation relatif |
| DE2818423A1 (de) * | 1978-04-27 | 1979-11-08 | Hoechst Ag | Neue isochinolinderivate und verfahren zu ihrer herstellung |
| IN154317B (pt) * | 1979-07-19 | 1984-10-13 | Andre Buzas | |
| DE3034001A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung |
-
1983
- 1983-05-19 US US06/496,327 patent/US4544657A/en not_active Expired - Fee Related
-
1984
- 1984-05-17 MC MC841707A patent/MC1597A1/xx unknown
- 1984-05-17 FI FI841992A patent/FI81795C/fi not_active IP Right Cessation
- 1984-05-17 DK DK248484A patent/DK248484A/da not_active Application Discontinuation
- 1984-05-17 NZ NZ208186A patent/NZ208186A/en unknown
- 1984-05-17 CA CA000454531A patent/CA1243028A/en not_active Expired
- 1984-05-17 GR GR74757A patent/GR82015B/el unknown
- 1984-05-17 ZA ZA843748A patent/ZA843748B/xx unknown
- 1984-05-17 IL IL71860A patent/IL71860A/xx unknown
- 1984-05-18 KR KR1019840002721A patent/KR840009102A/ko not_active Application Discontinuation
- 1984-05-18 AU AU28356/84A patent/AU570044B2/en not_active Ceased
- 1984-05-18 ES ES532603A patent/ES532603A0/es active Granted
- 1984-05-18 HU HU841916A patent/HU192555B/hu not_active IP Right Cessation
- 1984-05-18 PH PH30693A patent/PH19670A/en unknown
- 1984-05-18 PT PT78618A patent/PT78618A/pt not_active IP Right Cessation
- 1984-05-18 JP JP59098863A patent/JPS59222478A/ja active Pending
- 1984-05-18 NO NO842003A patent/NO159271C/no unknown
- 1984-05-21 DE DE8484105777T patent/DE3468875D1/de not_active Expired
- 1984-05-21 AT AT84105777T patent/ATE32072T1/de not_active IP Right Cessation
- 1984-05-21 EP EP84105777A patent/EP0126480B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8601141A1 (es) | 1985-11-01 |
| ATE32072T1 (de) | 1988-02-15 |
| PT78618A (en) | 1984-06-01 |
| AU570044B2 (en) | 1988-03-03 |
| FI841992A (fi) | 1984-11-20 |
| ES532603A0 (es) | 1985-11-01 |
| HUT34185A (en) | 1985-02-28 |
| ZA843748B (en) | 1985-01-30 |
| FI81795B (fi) | 1990-08-31 |
| DK248484D0 (da) | 1984-05-17 |
| IL71860A0 (en) | 1984-09-30 |
| FI81795C (fi) | 1990-12-10 |
| AU2835684A (en) | 1984-11-22 |
| CA1243028A (en) | 1988-10-11 |
| US4544657A (en) | 1985-10-01 |
| FI841992A0 (fi) | 1984-05-17 |
| KR840009102A (ko) | 1984-12-24 |
| NO842003L (no) | 1984-11-20 |
| HU192555B (en) | 1987-06-29 |
| GR82015B (pt) | 1984-12-12 |
| MC1597A1 (fr) | 1985-05-09 |
| DE3468875D1 (en) | 1988-02-25 |
| DK248484A (da) | 1984-11-20 |
| JPS59222478A (ja) | 1984-12-14 |
| EP0126480A1 (de) | 1984-11-28 |
| PH19670A (en) | 1986-06-09 |
| EP0126480B1 (de) | 1988-01-20 |
| NO159271B (no) | 1988-09-05 |
| NZ208186A (en) | 1987-06-30 |
| IL71860A (en) | 1987-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO162518C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 8-klor-1,5-benzothiazepinderivater. | |
| NO168353C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(2'-aminofenyl)-benzamidderivater | |
| NO163568C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| NO155490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-(1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl. | |
| NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
| NO157452C (no) | Analogifremgangsmaate for fremstilling av et terapeutisk aktivt bispidinderivat. | |
| NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
| NO881835D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
| NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
| NO159271C (no) | Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater. | |
| ES2035915T3 (es) | Agentes antiarritmicos n-fenetil-aminoalquil-benzamida. | |
| EP0471388A3 (de) | Mittel zur Behandlung der Herzinsuffizienz | |
| NO840732L (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin | |
| SE8400629L (sv) | Basiska oximetrar | |
| ATE121623T1 (de) | Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie. | |
| NO823676L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| NO156410C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6aaa-methylprednisolonderivater. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |